Veterinary Stereotactic Radiosurgery System Market Size

Veterinary Stereotactic Radiosurgery System Market size was valued at USD 412.3 million and is projected to grow at a CAGR of 9.3% from 2024 to 2032. The market's growth is due to the rising incidence of cancer in animals. With increased awareness of advanced treatment options, pet owners are seeking accurate and precise radiation therapies for treating their pets' cancerous tumors.

For example, middle-aged and older dogs, being more susceptible to tumors, benefit significantly from these non-invasive treatments. A study published in the Aging and Cancer Journal in February 2022 highlighted that one in four dogs would be diagnosed with cancer during their lifetime. Furthermore, research from Nature Journal in October 2021 identified cancer as a primary reason for veterinary consultations in the UK. This growing demand for specialized cancer care in dogs underscores the rising need for cancer therapies, driving the adoption of stereotactic radiosurgery systems. Such trends highlight the market's promising growth trajectory in the years ahead.

Stereotactic radiosurgery stands out as it delivers concentrated doses of radiation directly to tumors while safeguarding the surrounding healthy tissues. This precision makes it a preferred choice for cancer treatments. Additionally, advancements in imaging techniques and enhanced treatment planning systems are propelling the growth of this market.

A veterinary stereotactic radiosurgery system is a specialized device in veterinary medicine, designed to administer precise, high-dose radiation therapy for treating tumors in animals. It is especially effective for areas like the brain and spine. Leveraging innovative imaging and computer-guided technology, this non-invasive system targets tumors with sub-millimeter precision, significantly reducing potential harm to adjacent healthy tissues.